Klein v. Autek Corp.

147 F. App'x 270
CourtCourt of Appeals for the Third Circuit
DecidedSeptember 1, 2005
Docket04-3072
StatusUnpublished
Cited by6 cases

This text of 147 F. App'x 270 (Klein v. Autek Corp.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Third Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Klein v. Autek Corp., 147 F. App'x 270 (3d Cir. 2005).

Opinions

OPINION OF THE COURT

FUENTES, Circuit Judge.

Plaintiffs appeal from the District Court’s dismissal of their securities fraud claim for failing to comply with the heightened pleading requirements of the Private Securities Litigation Reform Act (“PSLRA”), 15 U.S.C. § 78u-4 et seq., and Federal Rule of Civil Procedure 9(b). Plaintiffs contend that the District Court misapplied the rigorous pleading requirements of the PSLRA and Rule 9(b). Plaintiffs also contend that the District Court erred in denying them leave to amend their complaint for a second time. We affirm substantially for the reasons expressed in the thorough and persuasive opinion of the District Court. We add the following discussion to underscore our own agreement with that decision.

I.

Plaintiffs invested approximately $2.1 million in Collective Communications Corporation (“Collective”), a start-up company formed in the late 1990s to market a secure wireless information network that would enable corporate databases to communicate with personal digital assistants. After Collective filed for bankruptcy, Plaintiffs brought an action alleging claims for, among others, securities fraud under § 10(b) of the Securities Exchange Act of 1934, 15 U.S.C. § 78j(b), and Rule 10b-5 against several defendants, including Atul Chowdhry and his relatives Neil and Sunita Chowdhry; Collective’s outside attorney Stephen M. Rosenberg; and Rosenberg’s former law firms, Cowan Liebowitz & Latinan, P.C. (“Cowan Liebowitz”) and Jenkens & Gilchrest Parker Chapin, LLP [273]*273(“Jenkens”).1 As stated in the Amended Complaint, the Plaintiffs allege that the Defendants, principally Atul Chowdhry and Rosenberg, made several oral and written misrepresentations to induce the Plaintiffs to invest in Collective, including: (1) that Collective’s liabilities were $250,000, a figure that failed to account for actual accrued liabilities to Tata Infoteeh, Ltd. (“Tata”), and unpaid bills to outside firms; (2) that Collective had a proprietary right in the billing software to be licensed from Tata, when in reality Tata refused to negotiate a sub-license with Collective until outstanding bills had been paid; and (3) that Autek Corporation, a corporation affiliated "with Chowdhry, was owed money by Collective, when in fact Autek’s corporate status had been revoked.

The District Court dismissed the Plaintiffs’ initial complaint, noting that “it is nearly impossible to discern from the instant pleading precisely which defendants are alleged to have made direct misstatements to which plaintiffs, what those misstatements were, when they were made, how they were false, and why each defendant is alleged to have acted with the requisite degree of scienter.” App. at 280. The District Court sua sponte granted Plaintiffs leave to amend, an opportunity which the Plaintiffs failed to seize. As the District Court noted, “[g]iven an opportunity to file an Amended Complaint, Plaintiffs made a strategic decision to include very little additional information. In sum and substance, the Amended Complaint is highly similar to the original Complaint [but for a few new paragraphs].” App. at 7.

II.

Our review of the District Court’s dismissal of the Amended Complaint pursuant to Rule 12(b)(6) is plenary. See In re Alpharma, Inc. Sec. Litig., 372 F.3d 137, 146 (3d Cir.2004). We must “accept as true all of the factual allegations in the complaint as well as the reasonable inferences that can be drawn from them and may dismiss the complaint only if it is clear that no relief could be granted under any set of facts that could be proved consistent with the allegations.” Id. (quotation and citation omitted). The District Court’s denial of leave to amend the Amended Complaint is reviewed for an abuse of discretion. See id. at 153. Leave to amend may be denied where the amendment would cause undue delay or prejudice, or where the amendment would be futile. Id. We have jurisdiction over the District Court’s order pursuant to 28 U.S.C. § 1291.

III.

Plaintiffs raise several arguments on appeal, all of which we find unpersuasive. First, we reject the Plaintiffs’ argument that the rigorous pleading requirements of the PSLRA should be relaxed in this case to the extent that no class action lawsuit is involved, which the Plaintiffs contend was the principal focus of the PSLRA. We note that 15 U.S.C. § 78u-4(b), which contains the heightened pleading requirements applicable to this matter, is titled “Requirements for securities fraud actions” and plainly states that it applies to “any private action under this chapter,” without reference to whether the action is brought as a class action or not. Moreover, we note that a different provision of the PSLRA, 15 U.S.C. § 78u-4(a), specifically states that it applies only to “Private [274]*274class actions,” thus reinforcing our view that Congress intended 15 U.S.C. § 78u-4(b) to apply to all private actions. See 15 U.S.C. § 78u-4(a) (stating that “[t]he provisions of this subsection shall apply in each private action ... brought as a plaintiff class action”). In light of the plain language of the PSLRA, we can see no basis to relax the pleading requirements applicable to securities fraud claims that do not involve class actions.

Neither does our decision in EP Medsystems, Inc. v. EchoCath, Inc., 235 F.3d 865 (3d Cir.2000), require a different conclusion. In EP Medsystems, a single corporate plaintiff brought a securities fraud action against a single corporate defendant, alleging that the defendant’s CEO made a misrepresentation with regards to the licensing prospects of the defendant’s new product line. On appeal, we reversed the district court’s dismissal of the complaint, finding that the PSLRA was to be applied less stringently because the plaintiffs complaint did “not fall into the pattern of the usual securities action.” Id. at 885; see also id. at 881 (noting that complaint was not “a ‘cookie cutter complaint’ or a class action brought by shareholders with an insignificant interest in the company; [rather] it [was] an individual action, based on a transaction arising from direct negotiations between the parties to the action”). This case bears no resemblance to EP Medsystems. While the cause of action in EP Medsystems was “more akin to a contract action than a securities action,” id.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
147 F. App'x 270, Counsel Stack Legal Research, https://law.counselstack.com/opinion/klein-v-autek-corp-ca3-2005.